These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 16173294)
1. Management of neurodegenerative disorders: Parkinson's disease and Alzheimer's disease. Pal PK; Netravathi M J Indian Med Assoc; 2005 Mar; 103(3):168-70, 172, 174-6. PubMed ID: 16173294 [TBL] [Abstract][Full Text] [Related]
2. Management of Parkinson's disease a review of current and new therapies. Mendis T; Suchowersky O; Lang A; Gauthier S Can J Neurol Sci; 1999 May; 26(2):89-103. PubMed ID: 10352867 [TBL] [Abstract][Full Text] [Related]
3. Management for motor and non-motor complications in late Parkinson's disease. Chan DK; Cordato DJ; O'Rourke F Geriatrics; 2008 May; 63(5):22-7. PubMed ID: 18447408 [TBL] [Abstract][Full Text] [Related]
4. Drug therapy for Parkinson's disease. Hermanowicz N Semin Neurol; 2007 Apr; 27(2):97-105. PubMed ID: 17390254 [TBL] [Abstract][Full Text] [Related]
5. Understanding Parkinson's disease: detection and early disease management. Mackin LA Lippincotts Prim Care Pract; 2000; 4(6):595-607. PubMed ID: 11933373 [TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease: diagnosis and treatment. Rao SS; Hofmann LA; Shakil A Am Fam Physician; 2006 Dec; 74(12):2046-54. PubMed ID: 17186710 [TBL] [Abstract][Full Text] [Related]
7. Treatment of levodopa-induced motor complications. Stocchi F; Tagliati M; Olanow CW Mov Disord; 2008; 23 Suppl 3():S599-612. PubMed ID: 18781681 [TBL] [Abstract][Full Text] [Related]
13. [Memantine can relieve certain symptoms in Parkinson disease. Improvement achieved in two out of three described cases with dyskinesia and cognitive failure]. Lökk J Lakartidningen; 2004 Jun; 101(23):2003-6. PubMed ID: 15232837 [TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease--challenges in new drug development. Babić T; Mahović D Coll Antropol; 2008 Dec; 32(4):1275-81. PubMed ID: 19149241 [TBL] [Abstract][Full Text] [Related]
15. Case studies in the advancement of Parkinson's disease. Frei K; Truong DD; Wolters E CNS Spectr; 2008 Dec; 13(12 Suppl 18):1-6. PubMed ID: 19179948 [TBL] [Abstract][Full Text] [Related]
16. Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease. Guay DR Am J Geriatr Pharmacother; 2006 Dec; 4(4):330-46. PubMed ID: 17296539 [TBL] [Abstract][Full Text] [Related]
17. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
19. [Olfactory disorders in Alzheimer's disease and in Parkinson's disease. Review of the literature]. Norès JM; Biacabe B; Bonfils P Ann Med Interne (Paris); 2000 Mar; 151(2):97-106. PubMed ID: 10855362 [TBL] [Abstract][Full Text] [Related]
20. Advances in the treatment of Parkinson's disease. Singh N; Pillay V; Choonara YE Prog Neurobiol; 2007 Jan; 81(1):29-44. PubMed ID: 17258379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]